Multicell Technologies Inc MCET:OTCPK

RT Quote | Exchange | USD
Last | 03/08/21 EST
0.0012quote price arrow up+0.0001 (+9.09%)
Volume
49,839,560
52 week range
0.00 - 0.01

...

Loading . . .

KEY STATS

  • Open0.001
  • Day High0.0012
  • Day Low0.001
  • Prev Close0.0012
  • 52 Week High0.01
  • 52 Week High Date02/17/21
  • 52 Week Low0.00
  • 52 Week Low Date08/14/20
  • Market Cap6.00M
  • Shares Out5.001B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta7.13
  • 1 Year % Change11,900

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-133.33
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-479,830.00
  • ROE (MRQ)-
  • Revenue (MRQ)810,000.00
  • Gross Margin (MRQ)5.74%
  • Net Margin (MRQ)-31.51%
  • Debt To Equity (MRQ)-31.91%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Multicell Technologies Inc News

There is no recent news for this security.

Latest MCET News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company. The Company and its subsidiaries are developing therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology, and peripheral vessel applications. The Company's portfolio of lead drug candidates is in various stages of discovery optimization, and preclinical and clinical development, and includes MCT-125, MCT-465, MCT-475 and...
W. Gerald Newmin
Chairman
Address
68 Cumberland St Ste 301
Woonsocket, RI
02895-3332
United States